Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT04179760 · COMPLETED
Trial details
- NCT number
- NCT04179760
- Sponsor
- SCM Lifescience Co., LTD.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-24
- Primary completion
- 2022-08-02
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.